Cost or cost effectiveness ‐ not reported · children aged 5 years and under
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Unintended adverse events ‐ not reported · children aged 5 years and under
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term impact (< 12 months) child fruit and vegetable intake · children aged 5 years and under
1 finding from 1 review
Cost‐effectiveness · children aged 5 years and under
1 finding from 1 review
Short‐term impact (< 12 months) unintended adverse events · children aged 5 years and under
1 finding from 1 review
Myocardial infarction · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (Vitamin B6 (pyridoxine;… showed no clear difference in myocardial infarction compared with placebo or standard care (high certainty).
1 finding from 1 review
Stroke · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (Vitamin B6 (pyridoxine;… leads to lower stroke compared with placebo or standard care (high certainty).
1 finding from 1 review
Death by any cause · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (Vitamin B6 (pyridoxine;… showed no clear difference in death by any cause compared with placebo or standard care (high certainty).
1 finding from 1 review
Adverse events · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (Vitamin B6 (pyridoxine;… showed no clear difference in adverse events compared with placebo or standard care (high certainty).
1 finding from 1 review
Cardiovascular events · people at high risk of or withcardiovascular disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical CVD events (CVD mortality and non‐fatal MI) · people at high risk of or withcardiovascular disease
It is very uncertain whether mindfulness‐based interventions (MBIs) changes clinical CVD events (CVD mortality and non‐fatal MI) compared with non‐active comparators (very low certainty).
1 finding from 1 review
Systolic blood pressure (mmHg), change from baseline · people at high risk of or withcardiovascular disease
1 finding from 1 review
Diastolic blood pressure (mmHg), change from baseline · people at high risk of or withcardiovascular disease
1 finding from 1 review
Anxiety · people at high risk of or withcardiovascular disease
1 finding from 1 review
Depression, change from baseline · people at high risk of or withcardiovascular disease
1 finding from 1 review
Perceived stress, change from baseline · people at high risk of or withcardiovascular disease
1 finding from 1 review
General well‐being · people at high risk of or withcardiovascular disease
1 finding from 1 review
Adverse events · people at high risk of or withcardiovascular disease
Mindfulness‐based interventions (MBIs) showed no clear difference in adverse events compared with non‐active comparators (low certainty).
1 finding from 1 review
Smoking cessation · people at high risk of or withcardiovascular disease
Mindfulness‐based interventions (MBIs) showed no clear difference in smoking cessation compared with non‐active comparators (low certainty).
1 finding from 1 review
Systolic blood pressure (mmHg), change from baseline · people at high risk of or withcardiovascular disease
1 finding from 1 review